Cancer of the ovary, fallopian tube, and peritoneum

被引：86

作者：

Berek, Jonathan S. ^{[1
]}

Crum, Christopher ^{[2
]}

Friedlander, Michael ^{[3
]}

机构：

[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford Womens Canc Ctr, Stanford, CA 94305 USA

[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA

[3] Royal Hosp Women, Sydney, NSW, Australia

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2012年 / 119卷

关键词：

GERM-CELL TUMORS; PHASE-III TRIAL; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; SECONDARY CYTOREDUCTIVE SURGERY; PACLITAXEL-BASED CHEMOTHERAPY; TERM-FOLLOW-UP; STAGE-III; INTRAPERITONEAL CISPLATIN; INTRAEPITHELIAL CARCINOMA;

D O I：

10.1016/S0020-7292(12)60025-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：S118 / S129

页数：12

共 107 条

[31] Long-term follow-up of women with ovarian cancer after positive second-look laparotomy [J].

Dowdy, SC ;

Constantinou, CL ;

Hartmann, LC ;

Keeney, GL ;

Suman, VJ ;

Hillman, DW ;

Podratz, KC .

GYNECOLOGIC ONCOLOGY, 2003, 91 (03) :563-568

[32]

Edge SB., 2010, AJCC CANC STAGING MA

[33] A phase II study of Gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer [J].

Friedlander, M ;

Millward, MJ ;

Bell, D ;

Bugat, R ;

Harnett, P ;

Moreno, JA ;

Campbell, L ;

Varette, C ;

Ripoche, V ;

Kayitalire, L .

ANNALS OF ONCOLOGY, 1998, 9 (12) :1343-1345

[34] Clinical Trials in Recurrent Ovarian Cancer [J].

Friedlander, Michael ;

Trimble, Edward ;

Tinker, Anna ;

Alberts, David ;

Avall-Lundqvist, Elisabeth ;

Brady, Mark ;

Harter, Philipp ;

Pignata, Sandro ;

Pujade-Lauraine, Eric ;

Sehouli, Jalid ;

Vergote, Ignace ;

Beale, Philip ;

Bekkers, Rudd ;

Calvert, Paula ;

Copeland, Lawrence ;

Glasspool, Ros ;

Gonzalez-Martin, Antonio ;

Katsaros, Dionysis ;

Kim, Jae Won ;

Miller, Brigitte ;

Provencher, Diane ;

Rubinstein, Lawrence ;

Atri, Mostafa ;

Zeimet, Alain ;

Bacon, Monica ;

Kitchener, Henry ;

Stuart, Gavin C. E. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) :771-775

[35] Symptom Control in Patients With Recurrent Ovarian Cancer Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer [J].

Friedlander, Michael ;

Butow, Phyllis ;

Stockler, Martin ;

Gainford, Corona ;

Martyn, Julie ;

Oza, Amit ;

Donovan, Heidi S. ;

Miller, Brigitte ;

King, Madeline .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 :S44-S48

[36] Paclitaxel-based chemotherapy in carcinoma of the Fallopian tube [J].

Gemignani, ML ;

Hensley, ML ;

Cohen, R ;

Venkatraman, E ;

Saigo, PE ;

Barakat, RR .

GYNECOLOGIC ONCOLOGY, 2001, 80 (01) :16-20

[37] TREATMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY WITH BLEOMYCIN, ETOPOSIDE, AND CISPLATIN [J].

GERSHENSON, DM ;

MORRIS, M ;

CANGIR, A ;

KAVANAGH, JJ ;

STRINGER, CA ;

EDWARDS, CL ;

SILVA, EG ;

WHARTON, JT .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :715-720

[38] Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan [J].

Gordon, AN ;

Fleagle, JT ;

Guthrie, D ;

Parkin, DE ;

Gore, ME ;

Lacave, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3312-3322

[39]

HACKER NF, 1983, OBSTET GYNECOL, V61, P413

[40] ORAL ETOPOSIDE IS ACTIVE AGAINST PLATINUM-RESISTANT EPITHELIAL OVARIAN-CANCER [J].

HOSKINS, PJ ;

SWENERTON, KD .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :60-63

← 1 2 3 4 5 6 7 8 9 10 →